Caring for uninsured patients with diabetes: Designing and evaluating a novel chronic care model for diabetes care

Journal of Evaluation in Clinical Practice

Volumn 16, Issue 4, 2010, Pages 700-706

  Khan, Mohammad A ^a   Evans, Arthur T ^b   Shah, Sejal ^a  

^a Division of Medical Toxicology   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

chronic care model; diabetes mellitus; health policy

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN GLARGINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ADULT; ARTICLE; BEDTIME DOSAGE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EMERGENCY CARE; FEMALE; FOLLOW UP; HEALTH BELIEF; HEALTH INSURANCE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; PATIENT CARE PLANNING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HOSPITAL; SYSTOLIC BLOOD PRESSURE; UNITED STATES; WEIGHT REDUCTION;

ADULT; CHICAGO; CHRONIC DISEASE; COHORT STUDIES; DIABETES MELLITUS; FEASIBILITY STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HOSPITALS, PUBLIC; HUMANS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; MODELS, THEORETICAL; PROGRAM EVALUATION; PROSPECTIVE STUDIES;

EID: 77954637408     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2009.01178.x     Document Type: Article

References (49)

1. National Center for Health Statistics (2009) Table 75: overweight, obesity, and healthy weight among persons 20 years of age and over, by sex, age, race, and Hispanic origin. In Health, United States, 2008 with Chartbook, p. 335.
2. Lethbridge-Cejku, M. Vickerie, J. (2003) Summary health statistics for U.S. adults: Table 7: frequencies of selected diseases and conditions among persons 18 years of age and over by selected characteristics: National Health Interview Survey, 2003. National Center for Health Statistics. Vital and Health Statistics. Series 10, 225, 28 29.
3. Wagner, E. H. (1998) Chronic disease management: what will it take to improve care for chronic illness? Effective Clinical Practice, 1, 2 4.
4. Khan, M., Kim, S., Channabasappa, S., Rajaram, V., Sai, T., Godwin, C. Schiff, G. D. (2002) Why walk-in? Better understanding reasons for visits in large urban public hospital ambulatory clinic. Poster presentation at: Midwest Society for General Internal Medicine 19th Annual Meeting; 28 September 2002; Chicago, IL.
5. Khan, M., Evans, A., Vargas, S., et al. (2003) An epidemic of diabetes mellitus in an urgent care center. Journal of General Internal Medicine, 18 (Suppl. 1 178.
6. Bodenheimer, T., Wagner, E. H. Grumbach, K. (2002) Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA: The Journal of the American Medical Association, 288, 1909 1914.
7. Bodenheimer, T., Wagner, E. H. Grumbach, K. (2002) Improving primary care for patients with chronic illness. JAMA: The Journal of the American Medical Association, 288, 1775 1779.
8. Deakin, T., McShane, C. E., Cade, J. E. Williams, R. D. (2005) Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online) 2 CD003417.
9. Conn, V. S., Valentine, J. C. Cooper, H. M. (2002) Interventions to increase physical activity among aging adults: a meta-analysis. Annals of Behavioral Medicine, 24, 190 200.
10. Ellis, S. E., Speroff, T., Dittus, R. S., Brown, A., Pichert, J. W. Elasy, T. A. (2004) Diabetes patient education: a meta-analysis and meta-regression. Patient Education and Counseling, 52, 97 105.
11. Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H. Engelgau, M. M. (2002) Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care, 25, 1159 1171.
12. Shojania, K. G., Ranji, S. R., McDonald, K. M., Grimshaw, J. M., Sundaram, V., Rushakoff, R. J. Owens, D. K. (2006) Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA: The Journal of the American Medical Association, 296, 427 440.
13. Yamaoka, K. Tango, T. (2005) Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care, 28, 2780 2786.
14. DiMatteo, M. R. (2004) Variations in patients' adherence to medical recommendation: a quantitative review of 50 years of research. Medical Care, 42, 200 209.
15. Ismail, K., Winkley, K. Rabe-Hesketh, S. (2004) Systematic review and meta-analysis of randomized controlled trails of psychological interventions to improve glycemic control in patients with type 2 diabetes. Lancet, 363, 1589 1597.
16. Peterson, A. M., Takiya, L. Finley, R. (2003) Meta-analysis of trails of interventions to improve medication adherence. American Journal of Health-System Pharmacy, 60, 657 665. (Pubitemid 36752868)
17. Takiya, L. N., Peterson, A. M. Finley, R. S. (2004) Meta-analysis of interventions for medication adherence to antihypertensive. The Annals of Pharmacotherapy, 38, 1617 1624.
18. Ebrahim, S. Smith, G. D. (1998) Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions. Journal of Public Health Medicine, 20, 441 448.
19. Warsi, A., Wang, P. S., LaValley, M. P., Avorn, J. Solomon, D. H. (2004) Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Archives of Internal Medicine, 164, 1694 1699.
20. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854 865.
21. Esteban, I., Mataix, A., Ausejo, M., Roque, M. Moher, D. (2005) Metformin monotherapy for type 2 diabetes mellitus. Saenz A, Fernandez. Cochrane Database of Systematic Reviews (Online) 3 CD002966.
22. Salpeter, S. R., Greyber, E., Pasternak, G. A. Salpeter, E. E. (2003) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Archives of Internal Medicine, 163, 2594 2602.
23. Dean, T., Sumit, R. Finlay, A. (2005) Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care, 28, 2345 2351.
24. Goudswaard, A. N., Furlong, N. J., Rutten, G. E., Stolk, R. P. Valk, G. D. (2004) Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online) 4 CD003418.
25. Smith, S. A. Murad, M. H. (2008) Long-acting insulin analogues do not improve glycemic control but do reduce nocturnal hypoglycemia in diabetes. Evidence-Based Medicine, 13 (3 79.
26. Yki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R. Heikkilä, M. (1999) Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Annals of Internal Medicine, 130, 389 396.
27. Law, M. R., Wald, N. J., Morris, J. K. Jordan, R. E. (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomized trials. BMJ, 326, 1427.
28. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macro vascular and micro vascular complications in type 2 diabetes: UKPDS 38. BMJ, 317, 703 713.
29. UK Prospective Diabetes Study Group (1998) Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ, 317, 720 726.
30. Shaughnessy, A. Slawson, D. (2003) What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ, 327, 266.
31. McCormack, J. Greenhalgh, T. (2000) Seeing what you want to see in randomized controlled trials: versions and perversions of UKPDS data. BMJ, 320, 1720 1723.
32. Eidelman, R. S., Hebert, P. R., Weisman, S. M. Hennekens, C. H. (2003) An update on aspirin in the primary prevention of cardiovascular disease. Archives of Internal Medicine, 163, 2006 2010.
33. Edwards, J. E. Moore, R. A. (2003) Statins in hypercholesterolemia: a dose-specific meta-analysis of lipid changes in randomized, double blind trials. BMC Family Practice, 4, 18.
34. Chen, H. S., Wu, T. E., Jap, T. S., Lin, S. H. Hsiao, L. C. (2008) Improvement of glycaemia control in subjects with type 2 diabetes by self-monitoring of blood glucose: comparison of two management programs adjusting bedtime insulin dosage. Diabetes, Obesity & Metabolism, 10, 34 40.
35. Deakin, T., McShane, C. E., Cade, J. E. Williams, R. D. (2005) Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database of Systemic Reviews, 2, CD003417.
36. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837 853.
37. Simonson, D. C., Kourides, I. A., Feinglos, M., Shamoon, H. Fischette, C. T. (1997) Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group. Diabetes Care, 20, 597 606.
38. Stenman, S., Melander, A. Groop, P. (1993) What is the benefit of increasing the sulfonylurea dose? Annals of Internal Medicine, 118, 169 172. (Pubitemid 23034800)
39. Berelowitz, M., Fischette, C., Cefalu, W., Schade, D. S., Sutfin, T. Kourides, I. A. (1994) Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care, 17, 1460 1464.
40. Wahlin-Boll, E., Sartor, G., Melander, A. Schersten, B. (1982) Impaired effect of sulfonylurea following increased dosage. European Journal of Clinical Pharmacology, 22, 21 25.
41. Simpson, S. H., Majumdar, S. R., Tsuyuki, R. T., Eurich, D. T. Johnson, J. A. (2006) Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. Canadian Medical Association Journal, 174, 169 174.
42. Siebenhofer, A., Plank, J., Berghold, A., Narath, M., Gfrerer, R. Pieber, T. R. (2004) Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews (Online) 4 CD003287.
43. Dormandy, J., Charbonnel, B., Eckland, D., Erdmann, E., Massi-Benedetti, M., Moules, I., Skene, A., Tan, M., Lefèbvre, P. Murray, G. (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet, 366, 1279 1289.
44. Richter, B., Bandeira-Echtler, E., Bergerhoff, K., Ckar, C. Ebrahim, S. H. (2006) Pioglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 4, CD006060.
45. Richter, B., Bandeira-Echtler, E., Bergerhoff, K., Ckar, C. Ebrahim, S. H. (2007) Rosiglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 3, CD006063.
46. Largo, R. M., Singh, P. P. Nesto, R. W. (2007) Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet, 370, 1129 1136.
47. Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A. -L. Neil, A. (2007) Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomized trial. BMJ, 335, 132 139.
48. Welschen, L. M., Bloemendal, E., Nijpels, G., Dekker, J. M., Heine, R. J., Stalman, W. A. B. Bouter, L. M. (2006) Self-monitoring of blood glucose probably an effective way to improve glycaemic control in patients with type 2 diabetes not taking insulin. Cochrane Library and Diabetes Care, 150 (33 1826 1829, UI Coates, V. E. (2008) Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 Diabetes (ESMON study): randomised controlled trial. BMJ, 336, 1174 1177.
49. Simon, J., Gray, A., Clarke, P., Wade, A., Neil, A. Farmer, A. (2008) Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ, 336, 1177 1180.